Search

everythinglearnresearchcommunity

for

Search:↓

Complex therapy is more effective for long-term control of scalp abscesses.

Moderate exercise improves skin health, but intense exercise without protection can harm it.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

People with hidradenitis suppurativa are more likely to have bipolar disorder than those with psoriasis or without skin conditions.

Dermal Papilla Cells grown in 3D and with stem cells better mimic natural hair growth conditions than cells grown in 2D.

IL6 is linked to higher risk of heart disease in people with a certain mouth condition.

The document covers various dermatological treatments and conditions.

Notch1 helps skin heal by attracting cells that aid repair.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Personality traits significantly affect the onset, progression, and psychological impact of alopecia areata.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Minoxidil and spironolactone can improve hair growth, but responses vary and side effects are common.

Peptides improve skin health and treatments for hair loss and pregnancy-related skin issues are evolving.

Dutasteride is more effective than finasteride for hair growth, and pregabalin effectively treats neuropathic pain.

Reducing iron levels didn't improve heart health or metabolism in women with certain ovarian issues.

Encapsulating hair loss drugs in cyclodextrins improves their solubility and reduces scalp irritation.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

Demodicosis is common and often missed, needing more recognition and treatment in skin care.